Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children.

Schlegel N, Bardet V, Kenet G, Muntean W, Zieger B, Nowak-Göttl U, Working Group on Standardisation in Perinatal and Pediatric Hemostasis

Research article (journal)

Abstract

Inherited disorders of platelets constitute a group of rare diseases that give rise to bleeding syndromes of variety severity, with more severe cases being first diagnosed during infancy and childhood. To appropriate diagnose a platelet function disorder during early childhood the knowledge of the physiological characteristics of platelets in the paediatric population is mandatory. Apart from thrombocytopenia which is quite common in neonates and children the present overview is aimed to focus on inherited platelet function disorders. Furthermore, knowledge on platelet maturation and reference values according to age are given, and a diagnostic strategy specifically adapted to a pediatric population is presented on the bases of plasmatic and molecular laboratory methodologies. Finally, therapeutic approaches are briefly summarized (antifibrinolytic agents, Desmopressin, HLA-matched platelets, recombinant factor VIIa).

Details about the publication

JournalKlinische Pädiatrie
Volume222
Issue3
Page range209-214
StatusPublished
Release year2010
Language in which the publication is writtenEnglish
DOI10.1055/s-0030-1249065
KeywordsInfant Newborn; von Willebrand Diseases; Factor VIIa; Platelet Transfusion; Blood Platelet Disorders; von Willebrand Factor; Antifibrinolytic Agents; Recombinant Proteins; Platelet Function Tests; Myosin Heavy Chains; DNA Mutational Analysis; Child; Humans; Molecular Motor Proteins; Thrombocytopenia; Partial Thromboplastin Time; Platelet Count; Hemorrhagic Disorders; Deamino Arginine Vasopressin; Syndrome; Infant; Diagnosis Differential; Infant Newborn; von Willebrand Diseases; Factor VIIa; Platelet Transfusion; Blood Platelet Disorders; von Willebrand Factor; Antifibrinolytic Agents; Recombinant Proteins; Platelet Function Tests; Myosin Heavy Chains; DNA Mutational Analysis; Child; Humans; Molecular Motor Proteins; Thrombocytopenia; Partial Thromboplastin Time; Platelet Count; Hemorrhagic Disorders; Deamino Arginine Vasopressin; Syndrome; Infant; Diagnosis Differential

Authors from the University of Münster

Nowak-Göttl, Ulrike
University Children's Hospital - Department of Paediatric Haematology and Oncology (UKM PHO)